logologo
QuantliQuantli

eXoZymes Inc

EXOZ

NASDAQ

Biotechnology

$5.82

USD

-0.18 (-3.00%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $48.26M

Volume 9.1K

Price (USD)
Price (USD)

About eXoZymes Inc

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

CEO

Mr. Michael Heltzen

HQ

Monrovia California, CALIFORNIA, US

Founded

2024

Employees

32

Key Metrics

2 metrics our research team weighs before forming a view on EXOZ.

Based on Quantli research · SEC filings · as of Q1 2026

METRIC

VALUE

CHANGE

TREND (3Y)

ROE (TTM)

-633.0%

Free Cash Flow (TTM)

$-7.09M

Financial Snapshot

Full Financials

Revenue

$0

YoY

Gross Margin

YoY

Net Income

$-9.67M

YoY

Operating Cash Flow

$-6.89M

YoY

Key Statistics

Open

$5.89

Previous Close

$6.00

Day Range

$5.82 - $6.49

52 Week Range

$4.35 - $18.40

Volume

9.1K

Average Volume (10 Days)

0

Dividend Yield

Valuation Measurement

Market Cap

$48.26M

P/E Ratio (TTM)

Price / Book

31.58

Financial Highlights

Return on Assets

-240.7%

Return on Equity

-633.0%

Revenue (TTM)

$0

Net Income (TTM)

$-9.67M

Diluted EPS (TTM)

-$1.15

Total Cash (MRQ)

$1.44M

Levered FCF (TTM)

$-7.09M

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Go deeper on EXOZ

Similar Stocks

APLM

Apollomics Inc

$23.40

+34.7%

XLO

Xilio Therapeutics Inc

$9.17

+1.8%

CLNN

Clene Inc

$4.14

-1.2%

INMB

INmune Bio Inc

$2.17

+4.3%

TIL

Instil Bio Inc

$7.38

+1.5%

ATYR

aTyr Pharma Inc

$0.5600

+1.1%

HRTX

Heron Therapeutics Inc

$0.3400

+0.7%

INKT

Mink Therapeutics Inc

$11.27

+2.5%

Earnings Calendar

Next Earnings

Estimated Q3 Release

Nov 09